JIANGSU HENGRUI MEDI

600276
End-of-day quote. End-of-day quote  - 12/03
49.2CNY +0.29%

Dalian Wanchun Brin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 100 million in funding from Jiangsu Hengrui Medicine Co., Ltd.

08/25/2021 | 12:00am
Dalian Wanchun Brin Pharmaceutical Co., Ltd. announced that it has entered into a capital increase and shareholding agreement for a private placement of common shares for gross proceeds of CNY 100 million on August 25, 2021. The transaction will include participation from Jiangsu Hengrui Medicine Co., Ltd. As a result, the investor will own more than 2.5% stake in the company. The transaction does not need to be submitted to the investor's board of directors and shareholders' meeting for deliberation. The transaction still needs the approval of relevant government departments.
© S&P Capital IQ 2021
Copier lien
All news about JIANGSU HENGRUI MEDICINE CO., LTD.
11/21
10/19
08/26
08/25
08/19